The world is facing a pandemic situation and everyone wants to know when the coronavirus vaccine will come out. Well, there are many Coronavirus vaccines still in works. But, Russia will give its first vaccine to the patient’s next week. There is a hope that the vaccine will make a difference in the health system and the economic life will get back to its normal stage.
Russian hospitals will give the antiviral drug and this is registered under the name ‘Avifair’. The vaccine will be given on 11th June. This drug would be manufactured enough so that in a month around 60,000 people are treated. Currently, there is no vaccine for COVID-19 and all the vaccines are on a trial basis to understand its effects on humans.
Remdesivir Wikipedia
One of the drug names remdesivir from Gilead has some effectiveness against COVID-19 and in some of the countries, it is given to the patients as an emergency option.
Russia’s Vaccine for Coronavirus
Avifavir generic name is favipiravir and this was developed in the late 1990s by the Japanese company and later it was moved into healthcare. With time, this drug has been modified and now many changes have been made in it. Within a few weeks, all the details about the drug will be shared. The Russian government approved the drug Avifavir on Saturday.
Accelerated process
The clinical trial of the drug was done on 330 people and they have shown successful results within four days. To give the drug approval there has been a special accelerated process and its manufacturing started in March.
The clinical trial to check the drug effect will take months and a large number of patients are included in this. The success of the drug needs to be checked in a better manner and more comprehensive trails need to be done.
One of the studies published back in the last months was around the antimalarial drug hydroxychloroquine which has been taken by US President Donald Trump. At times, he had said people should use the drug as there have been increased cases of COVID-19 all over the world.
Testing time was cut down
Russia was able to cut down the testing time scale because the drug is Japanese and it is Avifavir. This was first registered in 2014 and they had also undergone the testing process.
It might be possible this drug is a game-changer and it will help the healthcare system a lot. Many people are struggling with this critical condition. The drug will be a great help to restore economic activity. All over the world, many steps have been taken to reduce the infection rate along with the death toll.
Let’s see how effective the drug will be and how it will help the person to live a normal life. Till there is not any official vaccine you should follow the health care guidelines to take care of your health. If you like us to share information on any related topic or want to know more then please feel free to share it with us.
